$CGON has been mentioned 3 times over the past 12 months by 2 distinct FinTwit voices, with the first mention appearing on February 12, 2026, and the most recent on July 8, 2026. Jacob Plieth (@jacobplieth) is the most active voice discussing the ticker with 2 mentions, while InvestmentGuru (@investmentguru_) contributed 1 mention. Discussion has centered on $CGON's immunotherapy pipeline for bladder cancer and oncology, with mentions occurring within biotech sector commentary.